{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:50:25Z","timestamp":1780469425852,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1038\/74715","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:34:58Z","timestamp":1027672498000},"page":"451-454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Varicella vaccination: Evidence for frequent reactivation of the vaccine strain in healthy children"],"prefix":"10.1038","volume":"6","author":[{"given":"Philip R.","family":"Krause","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M.","family":"Klinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm0400_451_CR1","doi-asserted-by":"publisher","first-page":"922","DOI":"10.7326\/0003-4819-130-11-199906010-00017","volume":"130","author":"JI Cohen","year":"1999","unstructured":"Cohen, J.I., Brunell, P.A., Straus, S.E. & Krause, P.R. NIH conference: Recent advances in varicella-zoster virus infection.  Ann. Intern. Med. 130, 922\u2013932 (1999).","journal-title":"Ann. Intern. Med."},{"key":"BFnm0400_451_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0891-5520(05)70313-5","volume":"10","author":"M Wharton","year":"1996","unstructured":"Wharton, M. The epidemiology of varicella-zoster virus infections. Infect. Dis. Clin. North. Am. 10, 571\u2013581 (1996).","journal-title":"Infect. Dis. Clin. North. Am."},{"key":"BFnm0400_451_CR3","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJM198411223112107","volume":"311","author":"SE Straus","year":"1984","unstructured":"Straus, S.E.  et al. Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient. N. Engl. J. Med.  311, 1362\u20131364 (1984).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0400_451_CR4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.94.4.524","volume":"94","author":"Y Asano","year":"1994","unstructured":"Asano, Y., et al Experience and reason: Twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics  94, 524\u2013526 (1994).","journal-title":"Pediatrics"},{"key":"BFnm0400_451_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0022-3476(95)70106-0","volume":"127","author":"PR Krause","year":"1995","unstructured":"Krause, P.R. & Klinman, D.M. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J. Pediatr.  127, 518\u2013525 (1995).","journal-title":"J. Pediatr."},{"key":"BFnm0400_451_CR6","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJM198405313102201","volume":"310","author":"RE Weibel","year":"1984","unstructured":"Weibel, R.E., J, N.B. & Kuter, B.J. Live attenuated varicella vaccine: efficacy trial in healthy children. N. Engl. J. Med. 310, 1409\u2013 1415 (1984).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0400_451_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0264-410X(91)90189-D","volume":"9","author":"B Kuter","year":"1991","unstructured":"Kuter, B. et al. Oka\/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine  9, 643\u2013647 ( 1991).","journal-title":"Vaccine"},{"key":"BFnm0400_451_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/infdis\/172.3.706","volume":"172","author":"PW Choo","year":"1995","unstructured":"Choo, P.W., Donahue, J.G., Manson, J.E. & Platt, R. The epidemiology of varicella and its complications. J. Infect. Dis. 172, 706\u2013712 ( 1995).","journal-title":"J. Infect. Dis."},{"key":"BFnm0400_451_CR9","first-page":"750","volume":"109","author":"R Finger","year":"1994","unstructured":"Finger, R., Hughes, J., Meade, B., Pelletier, A. & Palmer, C. Age-specific incidence of chickenpox. Public Health Rep. 109, 750\u2013755 (1994).","journal-title":"Public Health Rep."},{"key":"BFnm0400_451_CR10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1542\/peds.92.6.833","volume":"92","author":"HH Bernstein","year":"1993","unstructured":"Bernstein, H.H.  et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka\/Merck varicella vaccine . Pediatrics 92, 833\u201383 (1993).","journal-title":"Pediatrics"},{"key":"BFnm0400_451_CR11","doi-asserted-by":"publisher","first-page":"S330","DOI":"10.1093\/infdis\/174.Supplement_3.S330","volume":"174","author":"T Varis","year":"1996","unstructured":"Varis, T. & Vesikari, T. Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J. Infect. Di.  174, S330\u20134 (1996).","journal-title":"J. Infect. Di."},{"key":"BFnm0400_451_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/infdis\/135.4.659","volume":"135","author":"J Luby","year":"1977","unstructured":"Luby, J., Ramirez-Ronda, C., Rinner, S., Hull, A. & Vergne-Marini, P. Alongitudinal study of varicella-zoster virus infections in renal transplant recipients. J. Infect. Dis.  135, 659\u2013663 ( 1977).","journal-title":"J. Infect. Dis."},{"key":"BFnm0400_451_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/infdis\/148.2.200","volume":"148","author":"A Arvin","year":"1983","unstructured":"Arvin, A., Koropchak, C. & Wittek, A. Immunologic Evidence of re-infection with varicella-zoster virus. J. Infect. Dis. 148, 200\u2013 205 (1983).","journal-title":"J. Infect. Dis."},{"key":"BFnm0400_451_CR14","first-page":"10","volume":"446","author":"H Tomita","year":"1988","unstructured":"Tomita, H., Tanaka, M., Kukimoto, N. & Ikeda, M. An ELISA study on varicella-zoster virus infection in acute peripheral facial palsy.  Acta Otolaryngol. (Stockh.) 446, 10\u2013 16 (1988).","journal-title":"Acta Otolaryngol. (Stockh.)"},{"key":"BFnm0400_451_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0934-8840(11)80285-9","volume":"278","author":"N Scheiermann","year":"1993","unstructured":"Scheiermann, N. & Gesemann, M. Anti-HBs antibody kinetics - A 4 year follow-up after hepatitis B vaccination. Zentralbl. Bakteriol. 278, 120\u2013126 (1993).","journal-title":"Zentralbl. Bakteriol."},{"key":"BFnm0400_451_CR16","first-page":"9","volume":"58","author":"RE Hope-Simpson","year":"1965","unstructured":"Hope-Simpson, R.E. The nature of herpes zoster: a long-term study and a new hypothesis.  Proc. R. Soc. Lond. 58, 9\u201320 (1965).","journal-title":"Proc. R. Soc. Lond."},{"key":"BFnm0400_451_CR17","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/infdis\/153.5.840","volume":"153","author":"P Ljungman","year":"1986","unstructured":"Ljungman, P.  et al. Clinical and subclinical reactivation of varicella-zoster virus in immunocompromised patients. J. Infect. Dis.  153, 840\u2013847 (1986).","journal-title":"J. Infect. Dis."},{"key":"BFnm0400_451_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/infdis\/165.1.119","volume":"165","author":"A Wilson","year":"1992","unstructured":"Wilson, A., Sharp, M., Koropchak, C.M., Ting, S.F. & Arvin, A.M. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J. Infect. Dis.  165, 119\u201326 (1992).","journal-title":"J. Infect. Dis."},{"key":"BFnm0400_451_CR19","unstructured":"Merck & Co. in Physician's Desk Reference 52nd edn. 1762\u20131765 (Medical Economics, Montvale, New Jersey, 1998)."},{"key":"BFnm0400_451_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.77.1.53","volume":"77","author":"PA Brunell","year":"1986","unstructured":"Brunell, P.A., Taylor, J., Geiser, C.F., Frierson, L. & Lydick, E. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics  77, 53\u201365 (1986).","journal-title":"Pediatrics"},{"key":"BFnm0400_451_CR21","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","volume":"325","author":"I Hardy","year":"1991","unstructured":"Hardy, I., Gershon, A.A., Steinberg, S.P. & LaRussa, P. The incidence of zoster after immunization with live attenuated varicella vaccine. N. Engl. J. Med. 325, 1545\u2013 1550 (1991).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0400_451_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jmv.1890320310","volume":"32","author":"EH Wasmuth","year":"1990","unstructured":"Wasmuth, E.H. & Miller, W.J. Sensitive ELISA for antibody to varicella-zoster virus using purified VZV glycoprotein antigen.  J. Med. Virol. 32, 189\u2013193 (1990).","journal-title":"J. Med. Virol."},{"key":"BFnm0400_451_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0166-0934(86)90048-0","volume":"14","author":"PM Keller","year":"1986","unstructured":"Keller, P.M., Lonergan, K., Neff, B.J., Morton, D.A. & Ellis, R.W. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of V ZV glycoprotein-specific antibodies. J. Virol. Meth.  14, 177\u2013188 (1986).","journal-title":"J. Virol. Meth."},{"key":"BFnm0400_451_CR24","first-page":"153","volume-title":"in Statistics in Medicine","author":"T Colton","year":"1974","unstructured":"Colton, T.  in Statistics in Medicine 153\u2013159 (Little, Brown, Boston, 1974)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm0400_451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm0400_451","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm0400_451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T18:45:49Z","timestamp":1659120349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0400_451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["BFnm0400_451"],"URL":"https:\/\/doi.org\/10.1038\/74715","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]},"assertion":[{"value":"9 November 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}